- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pharmacogenetics in United States
Total 323 results
-
Xspray Pharma ABCompletedPharmacokinetics | BioavailabilityUnited Kingdom
-
Amphastar Pharmaceuticals, Inc.Completed
-
Astellas Pharma Global Development, Inc.Yale UniversityCompletedHealthy Volunteers | Pharmacokinetics of ASP3662 | Displacement of RadiotracerUnited States
-
AstraZenecaCompletedPharmacokineticsUnited States, Hungary, Sweden, Australia, Belgium
-
Merckle GmbHCompletedPharmacokinetics | PharmacodynamicsUnited Kingdom
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid Tumors | Pharmacokinetics of 14C-labeled GilteritinibUnited States
-
AstraZenecaCompletedPharmacokinetics | Relative Bioavailability | AUC | CmaxUnited States
-
Astellas Pharma Global Development, Inc.TerminatedNon-hematologic Malignancies | Pharmacokinetics of ASP9853United States
-
Heptares Therapeutics LimitedCompletedBioavailability and PharmacokineticsUnited Kingdom
-
Daiichi Sankyo, Inc.CompletedPharmacokinetics | Tolerability | SafetyUnited Kingdom
-
Rock Creek Pharmaceuticals, Inc.CompletedPharmacokinetics of AnatabineUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedPharmacokinetics of ASP1707United Kingdom
-
AstraZenecaCompletedHealthy Volunteers | PharmacokineticsUnited Kingdom
-
Dent Neuroscience Research CenterTerminatedCentral Nervous System Effects of Diphenhydramine | Pharmacokinetics of DiphenhydramineUnited States
-
Lykos TherapeuticsNot yet recruitingPharmacokinetics | Hepatic ImpairmentUnited States
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International LtdCompletedHealthy Volunteers | Pharmacokinetics of Isavuconazole | Safety and Tolerability in ElderlyUnited States
-
Johns Hopkins UniversityCompletedHealthy Subjects | Cytochrome P450 CYP3A5 Enzyme Polymorphism | Pharmacokinetics of MaravirocUnited States
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
Astellas Pharma Global Development, Inc.CompletedHealthy Subjects | Pharmacokinetics of ASP4058 | Food Effect of ASP4058United States
-
Biota Pharmaceuticals, Inc.CompletedHealthy Volunteers | PharmacokineticsUnited States
-
Biota Pharmaceuticals, Inc.CompletedHealthy Volunteers | PharmacokineticsUnited States
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of Solifenacin Succinate | Bioavailability of Solifenacin SuccinateUnited States
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics | CardiovascularUnited Kingdom
-
Beckley Psytech LimitedCompletedPharmacokinetics in Healthy AdultsUnited Kingdom
-
Columbia UniversityOrganonCompletedPharmacokineticsUnited States
-
Auburn UniversityTuscaloosa Veterans Affairs Medical CenterWithdrawnDepressive Disorder, Major | Pharmacogenetics | Medication Therapy ManagementUnited States
-
e-Therapeutics PLCCompletedCancer | Pharmacokinetics | Tolerability | SafetyUnited Kingdom
-
Beckley Psytech LimitedCompletedPharmacokinetics in Healthy AdultsUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | EC905United Kingdom
-
Mutual Pharmaceutical Company, Inc.CompletedHealthy; Adult; Volunteer; Colchicine; Pharmacokinetics; Diltiazem; Cytochrome p450 3A4; P-glycoproteinUnited States
-
Astellas Pharma Global Development, Inc.Janssen Biotech, Inc.CompletedHealthy Subjects | Bioavailability of ASP015K | Pharmacokinetics of ASP015K | Food Effect of ASP015KUnited States
-
AstraZenecaCompletedSafety, Pharmacokinetics, Pharmacodynamics, Food EffectUnited Kingdom
-
AstraZenecaCompletedPharmacokinetics | Bioequivalence | Healthy Japanese SubjectsUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Volunteers | Pharmacokinetics of ASP3700United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of IpragliflozinUnited Kingdom
-
GenfitUniversity of Miami; Syneos HealthCompletedPharmacokinetics | Hepatic Impairment | Liver DiseaseUnited States
-
Columbia UniversityTerminatedPain | Evaluating Pharmacokinetics of Intranasal KetorolacUnited States
-
AstraZenecaCompletedHealthy Subjects | Pharmacokinetics | Tolerability | SafetyUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of ASP6294United Kingdom
-
Astellas Pharma Europe B.V.TerminatedHealthy Subjects | Pharmacokinetics of ASP2205United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Volunteers | Pharmacokinetics of ASP7962United Kingdom
-
Astellas Pharma Europe B.V.CompletedTolerability | Safety | Pharmacokinetics of ASP7962United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of ASP3652United Kingdom
-
Aegerion Pharmaceuticals, Inc.CompletedIntra-subject Variability of PharmacokineticsUnited Kingdom
-
Cardurion Pharmaceuticals, Inc.CompletedCardiovascular Diseases | Heart Failure | Pharmacokinetics | Clinical PharmacologyUnited States
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | EC905 | Multiple DoseUnited Kingdom
-
PfizerCompletedPharmacokinetics | Safety | ECGCanada, Spain, United States, Hungary, Poland, United Kingdom
-
PfizerCompletedPharmacokineticsUnited States
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Pharmacodynamics | Effect of RaceUnited Kingdom